Xiaorui Shi | Cardiovascular Research | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Xiaorui Shi

Oregon Health & Science University

                  Xiaorui Shi
Affiliation Oregon Health & Science University
Country United States
Scopus ID 7402952928
Documents 63
Citations 2,962
h-index 32
Subject Area Cardiovascular Research
Event International Popular Scientist Awards

Xiaorui Shi is a researcher affiliated with Oregon Health & Science University in the United States whose scholarly contributions have advanced the field of cardiovascular research. With an established publication record, substantial citation impact, and an h-index reflecting sustained scientific influence, Shi represents the profile of a researcher whose work contributes to the understanding of cardiovascular health, disease mechanisms, and translational medical science.[1]

Abstract

This article presents an academic overview of Xiaorui Shi, a cardiovascular researcher associated with Oregon Health & Science University. The profile highlights research productivity, scholarly influence, publication activity, and scientific contributions within cardiovascular medicine. The documented research record demonstrates sustained engagement in advancing scientific knowledge relevant to cardiovascular biology, clinical outcomes, and translational health research.[1]

Keywords

Cardiovascular Research; Clinical Science; Translational Medicine; Scientific Impact; Biomedical Research; Citation Analysis; Academic Recognition; Health Sciences.

Introduction

Cardiovascular disease remains one of the most significant global health challenges, motivating extensive research efforts aimed at understanding disease mechanisms and improving patient outcomes. Researchers operating in this field contribute through experimental studies, clinical investigations, epidemiological analyses, and translational initiatives that bridge laboratory discoveries with medical practice. Xiaorui Shi’s scholarly profile reflects participation in these scientific endeavors and demonstrates measurable academic influence through publications and citations.[1]

Research Profile

Xiaorui Shi is affiliated with Oregon Health & Science University and has established a recognized research presence in cardiovascular science. According to available bibliometric indicators, the researcher has authored 63 indexed documents, accumulated 2,962 citations, and achieved an h-index of 32. These indicators suggest a consistent record of publication and scholarly engagement within the biomedical research community.[1]

Research Contributions

The research contributions associated with Xiaorui Shi are situated within cardiovascular research, a multidisciplinary field encompassing molecular biology, physiology, clinical medicine, epidemiology, and therapeutic development. Scholarly work in this area contributes to understanding cardiovascular risk factors, disease progression, treatment strategies, and long-term health outcomes.[2]

Through peer-reviewed publications and collaborative investigations, Shi has contributed to the scientific literature that supports evidence-based approaches to cardiovascular health management. The citation record further indicates that published findings have been referenced by other researchers, reflecting ongoing relevance within the scientific community.[1]

Publications

A portfolio of 63 indexed publications reflects sustained academic productivity. Research outputs contribute to the broader body of cardiovascular literature and support scholarly communication through peer-reviewed dissemination channels. Publication activity is a central indicator of research engagement and scientific visibility within academic communities.[1]

Research Impact

Research impact is frequently assessed through citation metrics, publication quality, scholarly visibility, and influence on subsequent investigations. Xiaorui Shi’s citation count of 2,962 and h-index of 32 indicate that the published work has achieved measurable recognition among researchers and healthcare scientists. Such metrics suggest that the research has contributed meaningfully to ongoing scientific discussions and knowledge development within cardiovascular medicine.[1]

The influence of cardiovascular research extends beyond academia by informing clinical practice, supporting policy discussions, and contributing to improved patient care. Continued scholarly activity within this field remains essential for addressing evolving cardiovascular health challenges worldwide.[2]

Award Suitability

Based on documented research productivity, citation performance, institutional affiliation, and demonstrated scholarly influence, Xiaorui Shi presents a profile aligned with the objectives commonly associated with the Best Researcher Award. The combination of publication output, citation impact, and contribution to cardiovascular science supports consideration for recognition within academic and scientific award programs.[1]

Conclusion

Xiaorui Shi’s academic profile reflects sustained engagement in cardiovascular research and measurable scholarly impact. Through publications, citations, and contributions to biomedical science, the researcher has participated in advancing scientific understanding within an important area of health research. These achievements provide a foundation for academic recognition through programs such as the International Popular Scientist Awards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaorui Shi, Author ID 7402952928. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7402952928
  2. American Heart Association. (2021). Advances in cardiovascular research and translational medicine.
  3. International Popular Scientist Awards. (n.d.). Award information and recognition program.
    https://popularscientist.com/
  4. Shi, X., et al. (2024). Insights into stria vascular function, stria immunity, and age-related hearing loss.

Abdel Abdel-Rahman | Cardiovascular Pharmacology | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

Abdel Abdel-Rahman
East Carolina University, United States
Abdel Abdel-Rahman
Affiliation East Carolina University
Country United States
Scopus ID 7102847207
Documents 181
Citations 3711
h-index 33
Subject Area Cardiovascular Pharmacology
Event International Popular Scientist Awards
ORCID
0000-0002-3461-2190

Abdel Abdel-Rahman  the Innovative Research Award recognizes distinguished scientific contributions in the field of cardiovascular pharmacology and related biomedical sciences. Abdel Abdel-Rahman of East Carolina University has developed an extensive scholarly portfolio that reflects sustained academic productivity, interdisciplinary collaboration, and measurable scientific impact in cardiovascular research and pharmacological sciences.[1] His publication record, citation performance, and recognized expertise in cardiovascular pharmacology position him as a notable contributor within the international scientific community.[2]

Abstract

Abdel Abdel-Rahman has contributed extensively to cardiovascular pharmacology through scholarly investigations addressing vascular physiology, autonomic regulation, pharmacodynamics, and therapeutic mechanisms associated with cardiovascular disorders. His academic output demonstrates a strong emphasis on translational biomedical research and pharmacological innovation.[1] With 181 indexed documents, 3711 citations, and an h-index of 33, his work has achieved significant scholarly visibility and international academic engagement.[2] The Innovative Research Award acknowledges these contributions within the framework of the International Popular Scientist Awards program.

Keywords

The Innovative Research Award in Cardiovascular Pharmacology recognizes pioneering contributions that advance the understanding and treatment of cardiovascular diseases through pharmacological innovation and biomedical discovery. This award celebrates researchers whose work bridges Pharmacological Research, Biomedical Sciences, and Translational Medicine to develop safer, more effective cardiovascular therapeutics. It honors excellence in innovative drug development, clinical applications, and transformative scientific research that improves global cardiovascular health outcomes.

Introduction

Cardiovascular pharmacology remains an essential scientific discipline within biomedical research due to its role in understanding cardiovascular diseases, therapeutic mechanisms, and pharmacological interventions. Research within this domain contributes to the development of treatment strategies for hypertension, vascular dysfunction, and cardiac pathophysiology.[2]

Abdel Abdel-Rahman has maintained a sustained academic presence in this field through research activities associated with East Carolina University. His work demonstrates consistent scholarly productivity and scientific engagement within cardiovascular and pharmacological sciences.[1] The International Popular Scientist Awards recognize researchers whose scientific achievements contribute meaningfully to academic advancement and interdisciplinary biomedical knowledge.

Research Profile

The research profile of Abdel Abdel-Rahman reflects extensive engagement in cardiovascular pharmacology, autonomic regulation, neuropharmacology, and vascular function research. His scientific investigations have addressed mechanisms influencing blood pressure regulation, pharmacological responses, and cardiovascular signaling pathways.[2]

Bibliometric indicators associated with his scholarly output demonstrate sustained academic visibility. According to indexed scholarly databases, his work has accumulated thousands of citations and a notable h-index, indicating both productivity and citation influence within the biomedical research community.[2]

Research Contributions

Abdel Abdel-Rahman’s scientific contributions include investigations into cardiovascular regulation, pharmacological interactions, and neurovascular signaling. His studies have explored physiological mechanisms underlying vascular control and the pharmacodynamics associated with cardiovascular therapeutics.[5]

Several publications associated with his research profile have examined experimental pharmacological models relevant to cardiovascular disease mechanisms and therapeutic responses. These contributions have enhanced understanding of autonomic modulation and vascular pharmacology within preclinical and translational research contexts.[1]

Publications

The publication portfolio of Abdel Abdel-Rahman includes peer-reviewed articles focusing on cardiovascular pharmacology and related biomedical sciences. His indexed research output demonstrates continuity in scientific productivity and interdisciplinary collaboration.[1]

Representative publications indexed within international scholarly databases have contributed to citation growth and broader academic dissemination.[2]

Research Impact

The scientific impact of Abdel Abdel-Rahman’s work is reflected through citation metrics, publication visibility, and continued relevance within cardiovascular pharmacology research. His research output has contributed to ongoing academic discussions concerning cardiovascular physiology, vascular pharmacology, and therapeutic intervention strategies.

An h-index of 33 indicates consistent citation performance across multiple scholarly works, while a citation count exceeding 3700 demonstrates sustained engagement by the international biomedical research community.[2] These indicators collectively support the scholarly significance of his research activities.

Award Suitability

The Innovative Research Award recognizes individuals demonstrating substantial scientific contributions, scholarly influence, and research advancement within their respective disciplines. Abdel Abdel-Rahman’s academic profile aligns with these criteria through sustained publication activity, recognized citation impact, and research contributions within cardiovascular pharmacology.[1]

His scientific work reflects methodological rigor, interdisciplinary relevance, and ongoing contributions to pharmacological sciences. Participation in the International Popular Scientist Awards further highlights the importance of promoting impactful biomedical research and academic excellence.[1]

Conclusion

Abdel Abdel-Rahman’s scholarly record demonstrates a sustained commitment to cardiovascular pharmacology and biomedical research. Through extensive publication activity, measurable citation influence, and interdisciplinary scientific contributions, he has established a recognized academic presence within the international research community.[2] The Innovative Research Award acknowledges these accomplishments within the broader context of scientific advancement and research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Abdel Abdel-Rahman, Author ID 7102847207. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7102847207
  2. ORCID. (n.d.). ORCID profile for Abdel Abdel-Rahman.
    https://orcid.org/0000-0002-3461-2190
  3. International Popular Scientist Awards. (n.d.). Research recognition and scientific excellence initiatives.
    https://popularscientist.com/
  4. Katzung, B. G. (2021). Basic and Clinical Pharmacology. McGraw-Hill Education

Ander Ernaga Lorea | Cardiovascular Risk | Research Excellence Award

Published on by International Popular Scientist Awards

Mr. Ander Ernaga Lorea | Cardiovascular Risk | Research Excellence Award

Hospital Universitario de Navarra | Spain

Mr. Ander Ernaga Lorea is an endocrinologist with strong expertise in metabolic, thyroid, and cardiovascular endocrine disorders, integrating clinical practice with translational research. His research focuses on genomic medicine, familial hypercholesterolemia, thyroid carcinoma, acromegaly, and glucose metabolism, with leadership experience as a principal investigator in strategic genomic medicine initiatives. He has contributed as first author to multiple peer-reviewed, impact-factor journals addressing prognostic biomarkers, metabolic alterations, and rare endocrine presentations. His scholarly output demonstrates growing impact with citations of 178, an h-index of 6, and an i10-index of 4, supporting a rigorous, evidence-based approach that informs clinical decision-making, risk stratification, and personalized endocrine care.

Citation Metrics (Scopus)

120

90

60

30

0

Citations
65

i10-index
9

h-index
5

🟦 Citations   🟥 i10-index   🟩 h-index


View Scopus Profile        View Orcid Profile      View Google Scholar Profile

Featured Publications